Literature DB >> 22170114

Good response to cyclosporin in a child with acquired thrombocytopenic purpura.

Shuchita Jain1, Seema Kapoor, Ankur Singh, R N Mandal Ravi, Silky Jain.   

Abstract

Acquired amegakaryocytic thrombocytopenia is an unusual hematological disorder characterized by thrombocytopenia along with markedly diminished megakaryocytes in the bone marrow. There is no uniform consensus on the treatment and the case reports in pediatric age group are few. The authors report a child with this condition who responded to cyclosporine alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170114     DOI: 10.1007/s12098-011-0656-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  10 in total

1.  Successful cyclosporin A therapy for acquired amegakaryocytic thrombocytopenic purpura.

Authors:  Yoichi Azuno; Ken Yaga
Journal:  Am J Hematol       Date:  2002-04       Impact factor: 10.047

2.  Acquired amegakaryocytic thrombocytopenic purpura successfully treated with limited cyclosporin A therapy.

Authors:  Alfonso Quintás-Cardama
Journal:  Eur J Haematol       Date:  2002-09       Impact factor: 2.997

3.  Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course.

Authors:  Uzair B Chaudhary; Stephen F Eberwine; Kristen M Hege
Journal:  Am J Hematol       Date:  2004-03       Impact factor: 10.047

4.  Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin.

Authors:  M S Trimble; M F Glynn; M C Brain
Journal:  Am J Hematol       Date:  1991-06       Impact factor: 10.047

5.  Acquired amegakaryocytic thrombocytopenic purpura: review of a not very well-defined disorder.

Authors:  Antonio G Tristano
Journal:  Eur J Intern Med       Date:  2005-11       Impact factor: 4.487

6.  Acquired amegakaryocytic thrombocytopenic purpura.

Authors:  Neeraj Agarwal; Joseph E Spahr; Theresa L Werner; David L Newton; George M Rodgers
Journal:  Am J Hematol       Date:  2006-02       Impact factor: 10.047

Review 7.  Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature.

Authors:  S Lonial; P A Bilodeau; A A Langston; C Lewis; S Mossavi-Sai; J T Holden; E K Waller
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

8.  Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case report.

Authors:  R Kashyap; V P Choudhry; H P Pati
Journal:  Am J Hematol       Date:  1999-03       Impact factor: 10.047

9.  Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.

Authors:  W Kayser; H H Euler; N Schmitz; W Gassmann; H Löffler; F Asbeck
Journal:  Blut       Date:  1985-12

10.  Successful treatment with cyclosporin A in a child with acquired pure amegakaryocytic thrombocytopenic purpura.

Authors:  C T Peng; L Y Kao; C H Tsai
Journal:  Acta Paediatr       Date:  1994-11       Impact factor: 2.299

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.